ADIM
KURA icon

Alpha DNA Investment Management’s Kura Oncology KURA Stock Holding History

Alpha DNA Investment Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-41
Closed -$1K – 384
2021
Q1 		$1K Sell
41
-37
-47% -$1.17K ﹤0.01% 627
2020
Q4 		$2K Buy
+78
New +$2.74K ﹤0.01% 466

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Alpha DNA Investment Management's KURA Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Kura Oncology (KURA) in Q2 2021, closing a stake of 41 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in KURA in Q4 2020 and held it in 2 quarters. The position peaked at $2K in Q4 2020. 171 funds tracked by Wall St. Rank hold KURA as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Kura Oncology position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 41 Kura Oncology shares in Q2 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in Kura Oncology in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's Kura Oncology position peaked at $2K in Q4 2020.
  • 171 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.